Comparative Analysis of Intra-articular Injection of Steroid and/or Sodium Hyaluronate in Adhesive Capsulitis
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to compare the efficacy of intra-articular steroid injection, sodium hyaluronate injection, a combination of the two, and placebo in the treatment of adhesive capsulitis of the shoulder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 8, 2010
CompletedFirst Posted
Study publicly available on registry
June 15, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedDecember 19, 2013
December 1, 2013
2 years
June 8, 2010
December 17, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
SPADI Score (Shoulder Pain and Disability Index)
Postinjection 1month
Study Arms (4)
Isotonic saline
PLACEBO COMPARATORSteroid
EXPERIMENTALHyaluronate
EXPERIMENTALSteroid + Hyaluronate
EXPERIMENTALInterventions
* Total volume of injection drugs: 8ml * isotonic saline 4ml + telebrix(contrast media) 4ml * The number of injections : only once during the study period * Injection site : glenohumeral joint * Material : 22-gauze spinal needle * Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
* Total volume of injection drugs: 8ml * triamcinolone(40mg)1ml + isotonic saline 3ml + telebrix(contrast media)4ml * The number of injections : only once during the study period * Injection Site : glenohumeral joint * Material : 22-gauze spinal needle * Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
* Total volume of injection drugs: 8ml * sodium hyaluronate 2ml + isotonic saline 2ml + telebrix(contrast media)4ml * The number of injections : only once during the study period * Injection Site : glenohumeral joint * Material : 22-gauze spinal needle * Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
* Total volume of injection drugs: 8ml * triamcinolone(40mg)1ml + sodium hyaluronate 2ml + isotonic saline 1ml + telebrix(contrast media)4ml * The number of injections : only once during the study period * Injection Site : glenohumeral joint * Material : 22-gauze spinal needle * Anteroposterior, lateral, and axial arthrography after injection was performed to determine accuracy and patterns of the injection.
Eligibility Criteria
You may qualify if:
- clinical diagnosis : Adhesive Capsulitis of the Shoulder
- defining of adhesive capsulitis
- the presence of shoulder pain
- limitation of both active and passive movements of the glenohumeral joint of ≥25% in at list 2 directions(abduction,flexion,external rotation,internal rotation), as compared with the contralateral shoulder
- duration : symptomatic for \< 1 year
You may not qualify if:
- bilateral symptoms
- uncontrolled diabetes mellitus
- overt hypothyroidism or hyperthyroidism
- previous shoulder surgery
- previous glenohumeral joint injection within recent 6months
- trauma to the shoulder the last six months that required hospital care
- neurological symptoms
- allergy to injection material
- secondary adhesive capsulitis
- systemic inflammatory ds including rheumatoid arthritis
- degenerative arthritis of shoulder joint
- infectious arthritis of shoulder joint
- dislocation of shoulder joint
- blood coagulation disease
- rotator cuff tear
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine
Seoul, 156-707, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chris H. Jo, M.D., Ph.D
Joint & Spine Center, SMG-SNU Boramae Medical Center, Department of Orthopedic Surgery, Seoul National University College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, SMG-SNU Boramae Medical Center.
Study Record Dates
First Submitted
June 8, 2010
First Posted
June 15, 2010
Study Start
June 1, 2010
Primary Completion
June 1, 2012
Study Completion
December 1, 2013
Last Updated
December 19, 2013
Record last verified: 2013-12